Monsanto Co. (NYSE:MON) gapped up before the market opened on Wednesday . The stock had previously closed at $102.18, but opened at $102.88. Monsanto shares last traded at $104.57, with a volume of 3,536,310 shares trading hands.

MON has been the subject of several analyst reports. TheStreet lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Citigroup Inc. upped their price objective on Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. BMO Capital Markets set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th. Credit Agricole SA lowered Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 price objective for the company. in a research note on Thursday, September 15th. Finally, Deutsche Bank AG restated a “buy” rating and issued a $118.00 price objective on shares of Monsanto in a research note on Thursday, June 30th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Monsanto presently has an average rating of “Hold” and an average price target of $113.02.

The company has a 50-day moving average price of $105.82 and a 200 day moving average price of $100.43. The company has a market cap of $45.67 billion, a price-to-earnings ratio of 45.93 and a beta of 1.24.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing analysts’ consensus estimates of $2.40 by $0.23. The business had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.49 billion. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business’s revenue was down 8.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.39 earnings per share. On average, equities research analysts anticipate that Monsanto Co. will post $4.46 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.07%. Monsanto’s payout ratio is presently 89.26%.

In related news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.

A number of institutional investors have recently bought and sold shares of MON. WFG Advisors LP raised its position in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the last quarter. Howard Hughes Medical Institute acquired a new position in Monsanto during the first quarter worth $110,000. Signaturefd LLC raised its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC raised its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the last quarter. Finally, Pinkerton Retirement Specialists LLC raised its position in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the last quarter. Hedge funds and other institutional investors own 79.06% of the company’s stock.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.